Genes that encode receptor tyrosine kinases (RTKs) and their downstream signaling pathways are also viewed as the risk variants in GBM progression.[57] They have been found to involve in cell growth, migration, invasion, angiogenesis, metastasis, and chemoresistance in GBM (reviewed in ref. [151]). The gene discussed is NTRK1; the disease is glioblastoma.